| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And CFO
1 company
Patel Snehal is a CEO And CFO at Greenwich LifeSciences, Inc.. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $80.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 4,100 | $13.03 | $53,423.00 | - | +7.9% | -7.8% | |
| Feb 16, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 10,800 | $11.16 | $120,528.00 | +0.2% | +28.6% | +10.1% | |
| Feb 15, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 12,700 | $11.07 | $140,589.00 | +0.2% | +27.2% | +6.7% | |
| Nov 10, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 5,000 | $10.17 | $50,837.50 | - | -16.6% | +41.5% | |
| Nov 3, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 3,500 | $9.11 | $31,885.00 | - | -1.8% | +48.5% | |
| Oct 26, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,500 | $7.97 | $19,925.00 | - | +3.9% | +63.2% | |
| Oct 25, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,500 | $7.91 | $19,775.00 | - | +9.2% | +70.9% | |
| Oct 10, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,000 | $9.07 | $9,070.00 | - | +4.3% | +39.4% | |
| Oct 4, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,000 | $8.63 | $17,260.00 | - | +27.5% | +61.3% | |
| Sep 19, 2023 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 4,000 | $8.95 | $35,800.00 | - | +14.0% | +59.0% |